Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-045328
Filing Date
2011-08-09
Accepted
2011-08-09 15:19:09
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-14093_110q.htm 10-Q 630437
2 EX-31.1 a11-14093_1ex31d1.htm EX-31.1 9772
3 EX-31.2 a11-14093_1ex31d2.htm EX-31.2 9804
4 EX-32.1 a11-14093_1ex32d1.htm EX-32.1 4664
5 EX-32.2 a11-14093_1ex32d2.htm EX-32.2 4680
  Complete submission text file 0001104659-11-045328.txt   2721535

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sgyp-20110630.xml EX-101.INS 340420
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20110630.xsd EX-101.SCH 15604
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20110630_cal.xml EX-101.CAL 43425
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20110630_def.xml EX-101.DEF 76787
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20110630_lab.xml EX-101.LAB 236388
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20110630_pre.xml EX-101.PRE 112867
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35268 | Film No.: 111020523
SIC: 2834 Pharmaceutical Preparations